Leukocytapheresis for the treatment of refractory Henoch–Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy
Tóm tắt
Henoch–Schönlein purpura (HSP) is a childhood disorder, which is the vasculitis of systemic small vessels of unknown etiology. We encountered the dramatic efficacy of leukocytapheresis in a Japanese girl with refractory HSP resistant to combined prednisolone plus intravenous immunoglobulin therapy administration.
Tài liệu tham khảo
Ueki Y, Yamasaki S, Kanamoto Y, Kawazu T, Yano M, Matsumoto K, Miyake S, Tominaga Y, Iwamoto U, Suemitsu J, Matsuno Y, Sizume Y, Takenaka Y, Eguchi K (2000) Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford) 39:165–171
Sawada K, Ohnishi K, Fukui S, Yamada K, Yamamura M, Amano K, Wada M, Tanida N, Satomi M (1995) Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 30:322–329
Tanaka H, Tsugawa K, Nakahata T, Suzuki K, Ito E (2007) Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis. Clin Rheumatol 26:1014–1016
Fagbemi AAO, Torrente F, Hilson AJW, Thomson MA, Heuschkel RB, Murch SH (2007) Massive gastrointestinal haemorrhage in isolated intestinal Henoch–Schönlein purpura with response to intravenous immunoglobulin infusion. Eur J Pediatr 166:915–919
Kamitsuji H, Tani K, Yasui M, Taniguchi A, Taira K, Tsukada S, Iida Y, Kanki H, Fukui H (1987) Activity of blood coagulation Factor XIII as prognostic indicator in patients with Henoch–Schönlein purpura: efficacy of Factor XIII substitution. Eur J Pediatr 146:519–523
Nakahata T, Tanaka H, Suzuki K, Ito E (2003) Successful treatment with leukocytapheresis in refractory Henoch–Schönlein purpura. Clin Rheumatol 22:248–250